Emergent Biosolutions, Inc.
$6.80
-$0.22 (-3.13%)
$6.77Day Range$7.04
Key Statistics
Market Cap
$348.66M
Shares Outstanding
51.3M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
Nov 15, 2006
Round Lot
100
Locale
US
Trading Data
Day Open
$6.98
Day High
$7.04
Day Low
$6.77
Volume
1.87M
VWAP
$6.85
Prev Close
$7.02
Transactions
--
Acc. Volume
--
About Emergent Biosolutions, Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
PHARMACEUTICAL PREPARATIONSSIC 2834900 employees300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879240-631-3200IPO Nov 15, 2006US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001367644
- Composite FIGI
- BBG000GW06J7
- Share Class FIGI
- BBG001SP1G40
- Ticker Root
- EBS
- SIC Code
- 2834
About Emergent Biosolutions, Inc. (EBS) Stock
Emergent Biosolutions, Inc. (EBS) closed the 2026-09-18 session at $6.80, down 3.13% versus the previous close (-0.22). The stock opened at $6.98 and traded between $6.77 and $7.04 during that session. Session trading volume was 1.9M shares. The volume-weighted average price (VWAP) is $6.85.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Emergent Biosolutions, Inc. has a market capitalization of $348.7 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. EBS is listed on the XNYS exchange. The company employs approximately 900 people. Emergent Biosolutions, Inc. is headquartered in GAITHERSBURG, MD. The recorded listing date is 2006-11-15.
On this page you can find market EBS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.